Seer, Inc.
NASDAQ:SEERBiotechnology
+$0.01 today
- Market cap
- $77.30M
- Beta
- 1.59
- P/E (TTM)
- -1.4
- EPS (TTM)
- -$1.26
Volume 0.25M
Average 0.32M
Returns on capital
Seer, Inc. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
-28.4%
avg -19.8%
ROIC
-27.7%
avg -20.5%
ROA
-24.9%
avg -18.0%
Analysis
ROA is currently the strongest return metric at -24.9% versus its period average of -18.0%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Omid C. Farokhzad | Founder, President, Chief Executive Officer & Chair of the Board of Directors | USD 1.21M | 57 | — | — |
David R. Horn | President,Treasurer & Chief Financial Officer | USD 744.81K | 58 | 486.65K | 0.89% |
Asim Siddiqui | Senior Vice President of Research & Tech Development | — | — | — | — |
Charles Endweiss | Treasurer, Principal Financial Officer & Principal Accounting Officer | — | 49 | 65.00K | 0.12% |
Marissa Dixon | Chief People Officer | — | — | — | — |
Serafim Batzoglou | Chief Data Officer | — | — | — | — |
Kenny Ross | Chief Operations & Product Officer | — | — | — | — |
Anthony Bazarko | Chief Commercial Officer | — | — | — | — |
Martin Goldberg | Senior Vice President of Product Development | — | — | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Nov 2, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
5
$114,518.66
Net Transaction Value
−$114,518.66
Net selling
Most Active
Horn David R.
3 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Aug 18, 26Aug 18, 2026 | Horn David R. Direct | Sell | $14.8K$14,809.50 |
| Jul 8, 26Jul 8, 2026 | Nishar Dipchand Direct | Sell | $23.3K$23,265.45 |
| May 20, 26May 20, 2026 | Horn David R. Direct | Sell | $12.4K$12,351.56 |
| Feb 18, 26Feb 18, 2026 | Horn David R. Direct | Sell | $15.4K$15,446.51 |
| Feb 18, 26Feb 18, 2026 | Farokhzad Omid Direct | Sell | $48.6K$48,645.64 |
Summary
Insiders reported 0 buys worth $0.00 and 5 sells worth $114,518.66 over the last 12 months. That adds up to net selling of $114,518.66. Horn David R. was the most active insider with 3 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +3.2% | +24.1% (5yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Recent growth has been strongest in Revenue at +3.2% over three years. Forward estimates point to Revenue at +24.1% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does Seer, Inc. compete with?
Open similar companies to compare how their management teams allocate capital.
Competitors
Peer companies in the same sector
Kymera Therapeutics, Inc.
NASDAQ:KYMR
Market cap
$10.89B
Pharvaris N.V.
NASDAQ:PHVS
Market cap
$2.34B
Nurix Therapeutics, Inc.
NASDAQ:NRIX
Market cap
$1.69B
Mineralys Therapeutics, Inc.
NASDAQ:MLYS
Market cap
$1.36B
ORIC Pharmaceuticals, Inc.
NASDAQ:ORIC
Market cap
$814.71M
Monte Rosa Therapeutics, Inc.
NASDAQ:GLUE
Market cap
$800.67M
Cullinan Therapeutics, Inc.
NASDAQ:CGEM
Market cap
$667.39M
Sana Biotechnology, Inc.
NASDAQ:SANA
Market cap
$605.26M
Shattuck Labs, Inc.
NASDAQ:STTK
Market cap
$473.57M
C4 Therapeutics, Inc.
NASDAQ:CCCC
Market cap
$362.43M
Lyell Immunopharma, Inc.
NASDAQ:LYEL
Market cap
$351.57M
PepGen Inc.
NASDAQ:PEPG
Market cap
$301.98M
Quantum-Si incorporated
NASDAQ:QSI
Market cap
$229.78M
AN2 Therapeutics, Inc.
NASDAQ:ANTX
Market cap
$172.64M
Foghorn Therapeutics Inc.
NASDAQ:FHTX
Market cap
$124.12M
Molecular Partners AG
NASDAQ:MOLN
Market cap
$112.71M
Nkarta, Inc.
NASDAQ:NKTX
Market cap
$85.23M
MediciNova, Inc.
NASDAQ:MNOV
Market cap
$68.66M
Questions
Management questions
Common questions about SEER's management, answered from reported figures.
Who manages SEER?
Seer, Inc. (SEER) lists 9 active executives. The top listed executive is Asim Siddiqui, Senior Vice President of Research & Tech Development.
Are SEER insiders buying or selling?
Recent insider activity shows net buying of $3.65M.
Continue the stock analysis
Jump to another research area for this company.